News

Our strategic expansion in Japan: Reinforcing production to 2 billion tablets and aiming to be the “Most trusted CDMO”

Adragos Pharma is actively pursuing contract manufacturing in the Japanese market.  Leveraging ex-Sanofi’s Kawagoe plant (located Kawagoe City, Saitama Prefecture) which they acquired one year ago as their flagship manufacturing site, they are reinvesting on solid dosage manufacturing to serve […]

Adragos Pharma and Colonis Pharma strengthen their partnership

We are pleased to announce the strengthening of our long-established partnership with Colonis Pharma. This collaboration exemplifies our commitment to innovation and reliability in pharmaceutical product development and supply. Over a decade ago, our company, then known as Lamda Laboratories, […]

Fresenius Kabi’s Manufacturing Site in Norway successfully taken over by the Prange Group and Adragos Pharma

Plettenberg / Munich / Halden, 1st March 2024 – The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed the acquisition transaction of Fresenius Kabi production site in Halden, Norway – a leading sterile […]

Subscribe to our newsletter!

Get notified on our latest news.